MYND Life Sciences Inc.

MYND Life Sciences Inc.

MYNDF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$374.82K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MYND Life Sciences Inc.MYND Life Sciences Inc.-2.2-9%--0.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$374,824.00
Enterprise Value$3.37 Million
Earnings per Share$-0.03
Beta0.98
Outstanding Shares46,274,624

Return

Return on Equity9.06%ROE
Return on Assets-75.39%
Return on Invested Capital21.47%

Valuation & Multiples

P/E Ratio-2.18P/E Ratio
PEG7.64PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-2.62
Enterprise Value to Net Income-7
Total Debt to Enterprise0.89
Debt to Equity-0.5Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About MYND Life Sciences Inc.

0
CEO: Wilfred A. Jefferies

MYND Life Sciences Inc. operates as a neuro-pharmaceutical company, applying life science principles to develop innovative treatments for depressive conditions. The firm conducts scientific research and clinical trials in Canada and the ...